With 72 Nanomedicine related patents published between 2002 and 2022, Bristol-Myers Squibb Co holds the most number of Nanomedicine patents in the Middle East and Africa region, of which 80.6% was contributed by its subsidiary Abraxis BioScience, LLC.
The second largest number of Nanomedicine related patents were published by Pfizer Inc with 50 patents. The third largest number of Nanomedicine related patents were published by Selecta Biosciences Inc with 42 patents. The fourth largest number of Nanomedicine related patents were published by Perrigo Co Plc with 40 patents. The fifth largest number of Nanomedicine related patents were published by Nanobiotix SA with 33 patents.
The top five patent holders, i.e., Bristol-Myers Squibb Co, Pfizer Inc, Selecta Biosciences Inc, Perrigo Co Plc, and Nanobiotix SA, together held 237 Nanomedicine patents during the period.
Don’t wait - discover a universe of connected data & insights with your next search. Browse over 28M data points across 22 industries.
Access more premium companies when you subscribe to Explorer
Contact the team or request a demo to find out how our data can drive your business forward